IRB consolidation: Chesapeake expands services to meet growing demand
Chesapeake IRB has announced back-to-back acquisitions of two independent institutional review boards (IRBs) as the company aims to expand its services.
Chesapeake IRB has announced back-to-back acquisitions of two independent institutional review boards (IRBs) as the company aims to expand its services.
Proposed changes to drug, medical device and clinical testing regulations provide stimulus for conducting trials in China, says CRO George Clinical.
update
Teams of engineers at CordenPharma and Acasti Pharma came together to develop a proprietary continuous manufacturing process – which simplifies scale up and process re-validation.
ProSciento and OWL Metabolomics have formed a strategic collaboration to accelerate NAFLD/NASH clinical trial recruitment.
BASF has raised prices in Europe by as much as €300 per metric ton as demand returns for its butanediol-based chemicals.